These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37182062)

  • 1. Recurrent Bacterial Vaginosis: A Case Report and Review of Management.
    Safwat F; Safwat S; Daka N; Sivanathan N; Lazarevic M
    Cureus; 2023 Apr; 15(4):e37348. PubMed ID: 37182062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis.
    Recine N; Palma E; Domenici L; Giorgini M; Imperiale L; Sassu C; Musella A; Marchetti C; Muzii L; Benedetti Panici P
    Arch Gynecol Obstet; 2016 Jan; 293(1):101-107. PubMed ID: 26142892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactic acid gel versus metronidazole for recurrent bacterial vaginosis in women aged 16 years and over: the VITA RCT.
    Armstrong-Buisseret L; Brittain C; Kai J; David M; Anstey Watkins J; Ozolins M; Jackson L; Abdali Z; Hepburn T; Griffiths F; Montgomery A; Daniels J; Manley A; Dean G; Ross JD
    Health Technol Assess; 2022 Jan; 26(2):1-170. PubMed ID: 35057905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.
    van Schalkwyk J; Yudin MH;
    J Obstet Gynaecol Can; 2015 Mar; 37(3):266-274. PubMed ID: 26001874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent bacterial vaginosis following metronidazole treatment is associated with microbiota richness at diagnosis.
    Gustin AT; Thurman AR; Chandra N; Schifanella L; Alcaide M; Fichorova R; Doncel GF; Gale M; Klatt NR
    Am J Obstet Gynecol; 2022 Feb; 226(2):225.e1-225.e15. PubMed ID: 34560047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal Changes in Vaginal Microbiota and Genital Tract Cytokines Among South African Women Treated for Bacterial Vaginosis.
    Mtshali A; San JE; Osman F; Garrett N; Balle C; Giandhari J; Onywera H; Mngomezulu K; Mzobe G; de Oliveira T; Rompalo A; Mindel A; Abdool Karim SS; Ravel J; Passmore JS; Abdool Karim Q; Jaspan HB; Liebenberg LJP; Ngcapu S
    Front Immunol; 2021; 12():730986. PubMed ID: 34594336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing Recurrent Bacterial Vaginosis: Insights for Busy Providers.
    Marshall AO
    Sex Med Rev; 2015 Apr; 3(2):88-92. PubMed ID: 27784549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of recurrent bacterial vaginosis with tinidazole.
    Baylson FA; Nyirjesy P; Weitz MV
    Obstet Gynecol; 2004 Nov; 104(5 Pt 1):931-2. PubMed ID: 15516381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metatranscriptome Analysis of the Vaginal Microbiota Reveals Potential Mechanisms for Protection against Metronidazole in Bacterial Vaginosis.
    Deng ZL; Gottschick C; Bhuju S; Masur C; Abels C; Wagner-Döbler I
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and Treatment of Recurrent Bacterial Vaginosis.
    Faught BM; Reyes S
    J Womens Health (Larchmt); 2019 Sep; 28(9):1218-1226. PubMed ID: 31403349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial vaginosis: current review with indications for asymptomatic therapy.
    Thomason JL; Gelbart SM; Scaglione NJ
    Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 2):1210-7. PubMed ID: 1951577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Association Between Vaginal Microbiota Dysbiosis, Bacterial Vaginosis, and Aerobic Vaginitis, and Adverse Pregnancy Outcomes of Women Living in Sub-Saharan Africa: A Systematic Review.
    Juliana NCA; Suiters MJM; Al-Nasiry S; Morré SA; Peters RPH; Ambrosino E
    Front Public Health; 2020; 8():567885. PubMed ID: 33363078
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of bacterial vaginosis.
    Schlicht JR
    Ann Pharmacother; 1994 Apr; 28(4):483-7. PubMed ID: 8038475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of key species of vaginal bacteria of recurrent bacterial vaginosis patients before and after oral metronidazole therapy with short- and long-term clinical outcomes.
    Mollin A; Katta M; Sobel JD; Akins RA
    PLoS One; 2022; 17(7):e0272012. PubMed ID: 35901180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The vaginal microbiota among the different status of human papillomavirus infection and bacterial vaginosis.
    Liu Y; Li T; Guo R; Chen T; Wang S; Wu D; Li J; Liu Z; Zhao Y; Yin J; Qin J; Sun L; Chen W
    J Med Virol; 2023 Mar; 95(3):e28595. PubMed ID: 36811337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis.
    Gottschick C; Deng ZL; Vital M; Masur C; Abels C; Pieper DH; Rohde M; Mendling W; Wagner-Döbler I
    Microbiome; 2017 Sep; 5(1):119. PubMed ID: 28903767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of asymptomatic bacterial vaginosis with persistence of female genital human papillomavirus infection.
    Kero K; Rautava J; Syrjänen K; Grenman S; Syrjänen S
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2215-2219. PubMed ID: 28681204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment considerations for bacterial vaginosis and the risk of recurrence.
    Chen JY; Tian H; Beigi RH
    J Womens Health (Larchmt); 2009 Dec; 18(12):1997-2004. PubMed ID: 20044862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial Vaginosis: What Do We Currently Know?
    Abou Chacra L; Fenollar F; Diop K
    Front Cell Infect Microbiol; 2021; 11():672429. PubMed ID: 35118003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metronidazole versus lactic acid for treating bacterial vaginosis (VITA): protocol for a randomised controlled trial to assess the clinical and cost effectiveness of topical lactic acid gel for treating second and subsequent episodes of bacterial vaginosis.
    Armstrong-Buisseret L; Brittain C; David M; Dean G; Griffiths F; Hepburn T; Jackson L; Kai J; Montgomery A; Roberts T; Thandi S; Ross JDC
    Trials; 2019 Nov; 20(1):648. PubMed ID: 31775859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.